Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for DLB and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for DLB and 80,000+ other tickers.
See exactly how DLB's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DLB and 80,000+ other tickers.
Dolby Laboratories, Inc. develops pioneering audio and visual technologies designed to enhance entertainment and communication experiences across a broad spectrum of platforms. These include cinematic venues, digital television, various transmission and playback devices, mobile communications, online streaming video and music platforms, and home entertainment systems. The company is actively involved in inventing and licensing its advanced sound technologies. This portfolio features solutions like AAC & HE-AAC, a digital audio codec widely adopted for diverse media applications; AVC, a…
SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment, will release financial results for the fourth quarter (Q4) and full year fiscal 2026 after the close of regular trading on Tuesday, November 17, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q4 fiscal year 2026 financial results for Dolby Laboratories at 2:00 p.m.
Dolby Laboratories (NYSE: DLB - Get Free Report) and Palo Alto Networks (NASDAQ: PANW - Get Free Report) are both technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Risk and Volatility Dolby Laboratories has a
Dolby Laboratories (NYSE: DLB - Get Free Report) and Aware (NASDAQ: AWRE - Get Free Report) are both technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation. Profitability This table compares Dolby Laboratories and Aware's net
Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued share price despite weak growth. DLB's 90% gross margin and operating leverage enable EPS growth even with modest revenue increases and stagnant licensing. Share repurchases—authorized up to $427 million—could alone drive EPS to levels supporting a 15x multiple and 20%+ upside.
October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3 October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3